These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 10380572)
1. Description of a possible clonal expansion of Plasmodium vivax in Manaus-Amazonas-Brazil. Alecrim Mdos G; Alecrim WD; Macêdo V; Korves CT; Roberts DR; Li J; Sullivan M; McCutchan TF Rev Soc Bras Med Trop; 1999; 32(3):303-5. PubMed ID: 10380572 [TBL] [Abstract][Full Text] [Related]
3. Correlation between Plasmodium vivax variants in Belém, Pará State, Brazil and symptoms and clearance of parasitaemia. Machado RL; de Figuereido Filho AF; Calvosa VS; Figueredo MC; Nascimento JM; Póvoa MM Braz J Infect Dis; 2003 Jun; 7(3):175-7. PubMed ID: 14499040 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India. Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K Malar J; 2015 Aug; 14():310. PubMed ID: 26259839 [TBL] [Abstract][Full Text] [Related]
5. Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia. Orjuela-Sánchez P; da Silva NS; da Silva-Nunes M; Ferreira MU Am J Trop Med Hyg; 2009 Dec; 81(6):961-8. PubMed ID: 19996423 [TBL] [Abstract][Full Text] [Related]
6. Imported tertian malaria resistant to primaquine. Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431 [TBL] [Abstract][Full Text] [Related]
7. CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study. Brasil LW; Rodrigues-Soares F; Santoro AB; Almeida ACG; Kühn A; Ramasawmy R; Lacerda MVG; Monteiro WM; Suarez-Kurtz G Malar J; 2018 Feb; 17(1):57. PubMed ID: 29390987 [TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of chloroquine followed by primaquine for Plasmodium vivax treatment in Azerbaijan. Valibayov A; Abdullayev F; Mammadov S; Gasimov E; Sabatinelli G; Kondrachine AV; Ringwald P Acta Trop; 2003 Sep; 88(1):99-102. PubMed ID: 12943984 [TBL] [Abstract][Full Text] [Related]
12. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Marlar-Than ; Myat-Phone-Kyaw ; Aye-Yu-Soe ; Khaing-Khaing-Gyi ; Ma-Sabai ; Myint-Oo Trans R Soc Trop Med Hyg; 1995; 89(3):307-8. PubMed ID: 7660445 [TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria. Bright AT; Alenazi T; Shokoples S; Tarning J; Paganotti GM; White NJ; Houston S; Winzeler EA; Yanow SK Emerg Infect Dis; 2013 May; 19(5):802-5. PubMed ID: 23648098 [TBL] [Abstract][Full Text] [Related]
14. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India. Yadav RS; Ghosh SK J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158 [TBL] [Abstract][Full Text] [Related]
15. Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions. Ferreira MU; Nobrega de Sousa T; Rangel GW; Johansen IC; Corder RM; Ladeia-Andrade S; Gil JP Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():9-24. PubMed ID: 33360105 [TBL] [Abstract][Full Text] [Related]
16. Management of relapsing Plasmodium vivax malaria. Chu CS; White NJ Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil. Negreiros S; Farias S; Viana GM; Okoth SA; Chenet SM; de Souza TM; Marchesini P; Udhayakumar V; Povoa MM; Santelli AC; de Oliveira AM Am J Trop Med Hyg; 2016 Nov; 95(5):1061-1068. PubMed ID: 27549633 [TBL] [Abstract][Full Text] [Related]
18. Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping. Beck HP; Wampfler R; Carter N; Koh G; Osorio L; Rueangweerayut R; Krudsood S; Lacerda MV; Llanos-Cuentas A; Duparc S; Rubio JP; Green JA J Infect Dis; 2016 Mar; 213(5):794-9. PubMed ID: 26500351 [TBL] [Abstract][Full Text] [Related]
19. Global scenario of Plasmodium vivax occurrence and resistance pattern. Kaur D; Sinha S; Sehgal R J Basic Microbiol; 2022 Dec; 62(12):1417-1428. PubMed ID: 36125207 [TBL] [Abstract][Full Text] [Related]
20. SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria. Sortica VA; Lindenau JD; Cunha MG; O Ohnishi MD; R Ventura AM; Ribeiro-Dos-Santos ÂK; Santos SE; Guimarães LS; Hutz MH Pharmacogenomics; 2017 Oct; 18(15):1393-1400. PubMed ID: 28975866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]